ゲノムエンジニアリング市場：技術、用途、エンドユーザー別-2025年～2030年世界予測

ゲノムエンジニアリング市場は、2023年に63億3,000万米ドルと評価され、2024年には73億2,000万米ドルに達すると予測され、CAGR 15.68％で成長し、2030年には175億7,000万米ドルに達すると予測されています。

ゲノムエンジニアリングは、バイオテクノロジーの中でも変革的な分野であり、生物の遺伝物質を操作するために開発された技術や手法を包含します。その範囲には、CRISPR-Cas9、TALEN、ZFNなどの手法が含まれ、遺伝子治療、農業、合成生物学などの分野で可能性を広げています。ゲノムエンジニアリングの必要性は、遺伝子疾患、農作物の回復力、バイオ燃料の開発といった広範な課題に対処する可能性にあります。その用途は多岐にわたり、遺伝性疾患の撲滅などの治療用途、遺伝子組み換え作物による農業生産性の向上、ゲノムデータに基づく治療のカスタマイズによる個別化医療の進展などが含まれます。

最終用途はヘルスケア、農業、医薬品、産業バイオテクノロジーに及ぶ。この市場の主な成長要因としては、ゲノム編集技術の進歩、政府機関や民間機関からの資金提供の増加、健康成果や食糧安全保障を改善するためのバイオ技術革新に対する需要の高まりなどが挙げられます。新たなビジネスチャンスは遺伝子治療と精密医療に特に現れており、精密な遺伝子改変を可能にする画期的な技術によって、市場は大きな利益を得る態勢が整っています。企業は研究開発に投資し、規制の枠組みや倫理的配慮を把握しながら、改良された効率的で費用対効果の高いゲノム編集ツールの開発に注力することが推奨されます。

しかし、遺伝子操作に関する倫理的懸念や、迅速な商業化の妨げとなる厳しい規制要件など、市場は限界と課題に直面しています。また、ゲノム編集手順に関連する高いコストや、地域によっては限られた技術的専門知識も大きなハードルとなっています。イノベーションと研究は、これらの困難を克服することを目標とすべきです。有望な分野としては、効率改善とコスト削減のための送達メカニズムの進歩、マイクロバイオーム工学における新規アプリケーションの探求、害虫駆除のための環境に優しい遺伝子ドライブの開発などが挙げられます。

全体として、急速な成長と技術的進歩を特徴とするゲノムエンジニアリング市場は、大きな機会を提供しているが、その可能性を最大限に発揮するためには、倫理的・規制的状況を戦略的にナビゲートする必要があります。

市場力学：急速に進化するゲノムエンジニアリング市場の主要な市場インサイトの解明

ゲノムエンジニアリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオテクノロジー分野での合成遺伝子に対する需要の高まり
  • CRISPRゲノム編集技術の導入増加
  • 世界の診断分野での採用の増加
• 市場抑制要因
  • ゲノムエンジニアリングにおける高い装置/システムコスト
• 市場機会
  • 遺伝子編集ツールの絶え間ない技術開発
  • 個別化医療における新たな応用
• 市場の課題
  • 遺伝子工学に関連する問題

ポーターの5つの力：ゲノムエンジニアリング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ゲノムエンジニアリング市場における外部からの影響の把握

外部マクロ環境要因は、ゲノムエンジニアリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ゲノムエンジニアリング市場における競合情勢の把握

ゲノムエンジニアリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスゲノムエンジニアリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ゲノムエンジニアリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ゲノムエンジニアリング市場における成功への道筋を描く

ゲノムエンジニアリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオテクノロジー分野で合成遺伝子の需要が増加
    • CRISPRゲノム編集技術の導入拡大
    • 世界中で診断分野での採用が増加
  • 抑制要因
    • ゲノムエンジニアリングの設備/システムコストが高い
  • 機会
    • 遺伝子編集ツールの絶え間ない技術開発
    • 個別化医療における新たな応用
  • 課題
    • 遺伝子工学に関連する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ゲノムエンジニアリング市場：技術別

• 規則的に間隔を空けた短い回文の繰り返し
• 転写活性化因子様エフェクターヌクレアーゼ
• ジンクフィンガーヌクレアーゼ

第7章 ゲノムエンジニアリング市場：用途別

• 動物遺伝子工学
• 細胞株エンジニアリング
• 植物ゲノムエンジニアリング

第8章 ゲノムエンジニアリング市場：エンドユーザー別

• 学術機関および政府研究機関
• バイオテクノロジーおよび製薬会社
• 契約研究機関

第9章 南北アメリカのゲノムエンジニアリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のゲノムエンジニアリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのゲノムエンジニアリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bluebird Bio, Inc.
• CRISPR Therapeutics AG
• Danaher Corporation
• Editas Medicine, Inc.
• GenScript Biotech Corporation
• Horizon Discovery Group PLC
• Intellia Therapeutics, Inc.
• Lonza Group AG
• Merck & Co., Inc.
• New England Biolabs
• Origene Technologies
• Precision BioSciences, Inc.
• Sangamo Therapeutics, Inc.
• Thermo Fisher Scientific Inc.
• Transposagen Biopharmaceuticals, Inc.

LIST OF FIGURES

• FIGURE 1. GENOME ENGINEERING MARKET RESEARCH PROCESS
• FIGURE 2. GENOME ENGINEERING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENOME ENGINEERING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENOME ENGINEERING MARKET DYNAMICS
• TABLE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ZINC FINGER NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENOME ENGINEERING MARKET SIZE, BY PLANT GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENOME ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. CANADA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. CHINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. INDIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. ITALY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. POLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. QATAR GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

The Genome Engineering Market was valued at USD 6.33 billion in 2023, expected to reach USD 7.32 billion in 2024, and is projected to grow at a CAGR of 15.68%, to USD 17.57 billion by 2030.

Genome engineering, a transformative area within biotechnology, encompasses techniques and technologies developed to manipulate an organism's genetic material. Its scope includes methods such as CRISPR-Cas9, TALENs, and ZFNs, which have broadened possibilities in areas like gene therapy, agriculture, and synthetic biology. The necessity of genome engineering lies in its potential to address pervasive challenges such as genetic disorders, crop resilience, and the development of biofuels. Its applications are diverse, covering therapeutic uses like eradicating genetic diseases, enhancing agricultural productivity through genetically modified crops, and advancing personalized medicine by customizing treatments based on genomic data.

The end-use scope spans healthcare, agriculture, pharmaceuticals, and industrial biotechnology. Key growth influencers in this market include advancements in genome editing technologies, increasing funding from government bodies and private institutions, and rising demand for biotechnological innovations to improve health outcomes and food security. Emerging opportunities are particularly visible in gene therapy and precision medicine, with markets poised to benefit significantly from breakthroughs that allow for precise genetic modifications. Companies are advised to invest in R&D, focusing on the development of improved, efficient, and cost-effective genome editing tools while keeping abreast of regulatory frameworks and ethical considerations.

However, the market faces limitations and challenges, including ethical concerns around genetic manipulation and stringent regulatory requirements that can hinder rapid commercialization. High costs associated with genome editing procedures and limited technical expertise in some regions also pose significant hurdles. Innovation and research should target overcoming these difficulties, with promising areas including advancements in delivery mechanisms to improve efficiency and reduce costs, exploring novel applications in microbiome engineering, and developing eco-friendly gene drives for pest control.

Overall, the genome engineering market, characterized by rapid growth and technological advancements, presents significant opportunities but requires strategic navigation of ethical and regulatory landscapes to realize its full potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Engineering Market

The Genome Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for synthetic gene in biotechnology sector
  • Rising implementation of CRISPR genome editing technology
  • Increasing adoption in diagnostics sector worldwide
• Market Restraints
  • High equipment/systems costs in genome engineering
• Market Opportunities
  • Constant technological developments in gene-editing tools
  • Emerging application in personalized medicine
• Market Challenges
  • Issues associaetd with genetic engineering

Porter's Five Forces: A Strategic Tool for Navigating the Genome Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genome Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genome Engineering Market

A detailed market share analysis in the Genome Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Engineering Market

A strategic analysis of the Genome Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genome Engineering Market, highlighting leading vendors and their innovative profiles. These include Bluebird Bio, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Intellia Therapeutics, Inc., Lonza Group AG, Merck & Co., Inc., New England Biolabs, Origene Technologies, Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Transposagen Biopharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Genome Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease.
• Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering.
• Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for synthetic gene in biotechnology sector
    • 5.1.1.2. Rising implementation of CRISPR genome editing technology
    • 5.1.1.3. Increasing adoption in diagnostics sector worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High equipment/systems costs in genome engineering
  • 5.1.3. Opportunities
    • 5.1.3.1. Constant technological developments in gene-editing tools
    • 5.1.3.2. Emerging application in personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Issues associaetd with genetic engineering
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genome Engineering Market, by Technology

• 6.1. Introduction
• 6.2. Clustered Regularly Interspaced Short Palindromic Repeats
• 6.3. Transcription Activator-like Effector Nuclease
• 6.4. Zinc Finger Nuclease

7. Genome Engineering Market, by Application

• 7.1. Introduction
• 7.2. Animal Genetic Engineering
• 7.3. Cell Line Engineering
• 7.4. Plant Genome Engineering

8. Genome Engineering Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Government Research Institutes
• 8.3. Biotechnology & Pharmaceutical Companies
• 8.4. Contract Research Organizations

9. Americas Genome Engineering Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Genome Engineering Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Genome Engineering Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bluebird Bio, Inc.
• 2. CRISPR Therapeutics AG
• 3. Danaher Corporation
• 4. Editas Medicine, Inc.
• 5. GenScript Biotech Corporation
• 6. Horizon Discovery Group PLC
• 7. Intellia Therapeutics, Inc.
• 8. Lonza Group AG
• 9. Merck & Co., Inc.
• 10. New England Biolabs
• 11. Origene Technologies
• 12. Precision BioSciences, Inc.
• 13. Sangamo Therapeutics, Inc.
• 14. Thermo Fisher Scientific Inc.
• 15. Transposagen Biopharmaceuticals, Inc.